||||Page||
|---|---|---|---|---|
|Report oftheTrustees||1|to|3|
|Independent<br>Examiner's|Report||||
|Statement ofFinancial Activities|||||
|Balance Sheet|||||
|Notes tothe Financial Statements||7|to|10|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 



## 



## 

||||||2021|2020|
|---|---|---|---|---|---|---|
||||||Unrestricted|Total|
||||||fund|funds|
|||||Notes|f|E|
|INCOME AND ENDOWMENTS||FROM|||||
|Investment<br>income|||||25,165|37,636|
|EXPENDITURE ON|||||||
|Charitable<br>activities|||||||
|General donations to other charitable|||causes||38,000|34,500|
|Other|||||930|1 170|
|Total|||||38,930|35,670|
|Net gains/(losses)<br>on|investments||||215,450|(201,940)|
|NET INCOME/(EXPENDITURE)|||||201,685|(199,974)|
|RECONCILIATION<br>OF|FUNDS||||||
|Total funds brought|forward||||808,773|1,008,747|
|TOTAL FUNDS CARRIED FORWARD|||||1,010,458|808,773|





## 

## 

## 

|||2021|2020|
|---|---|---|---|
|||Unrestricted|Total|
|||fund|funds|
||Notes|E|E|
|FIXED ASSETS||||
|Investments||1,012,362|796,912|
|CURRENTASSETS||||
|Cash at bank||8,786|12,550|
|CREDITORS||||
|Amounts<br>falling due within one year||(10,690)|(689)|
|NET CURRENT ASSETS||(1,904)|11,861|
|TOTAL ASSETS LESS CURRENT LIABILITIES||1,010,458|808,773|
|NET ASSETS||1,010 458<br>7|808,773|
|FUNDS||||
|Unrestricted<br>funds||1,010,458|808,773|
|TOTALFUNDS||1010838|808 773|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 




## 

## 

## 

|||||2021|2020|
|---|---|---|---|---|---|
|||||E|E|
|General donations to other charitable|||causes|38,000|34,500|
|The total grants|paid to institutions|during the year was as follows:||||
|||||2021|2020|
|||||E|E|
|Motor Neurone||||2,000|2,000|
|Samaritans||||2,000||
|EDT Engineering|Trust||||12,500|
|Wye Hops||||10,000|10,000|
|Young Classical|Artists Trust|||10,000|10,000|
|Read Easy||||12,500||
|MenCap||||1,500||
|||||38,000|34,500|



## 

## 

## 

## 

## 

|FIXEDASSET INVESTMENTS||
|---|---|
||Listed|
||investments|
||f|
|MARKET VALUE||
|At 6 April 2020|796,912|
|Revaluations|215,450|
|At 5 April 2021|1,012,362|
|NET BOOK VALUE||
|At 5 April 2021|1,012,362|
|At 5 April 2020|796,912|





## 

## 

## 

## 


|||||Market|||
|---|---|---|---|---|---|---|
|Holding||||Value|5.4.21|5.4.20|
|||||E||Df3|
|Unilever||||345,812|34.16N|43.56ND|
|Scottish Mortgage|Investment||Trust|291,000|28.74%|16.89N|
|Royal Dutch Shell||||85,172|8.41/|11.35%|
|M&G Equities Investment||Fund||69,594|6.87%|6.8142I'|
|Astrazeneca||||82,478|8.1596|10.31%|
|Prudential||||65,551|6.48%|4.88%|





## 

## 

|6.|CREDITORS: AMOUNTS|FALLING DUE WITHIN ONE YEAR|||
|---|---|---|---|---|
||||2021|2020|
||||E|E|
||Trade creditors||10,000||
||Other creditors||690|689|
||||10,690|689|



##